Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

23andMe Holding Q1 2025 GAAP EPS $(0.14), Sales $40.000M Miss $52.050M Estimate

Author: Benzinga Newsdesk | August 08, 2024 04:22pm
23andMe Holding (NASDAQ:ME) reported quarterly losses of $(0.14) per share. The company reported quarterly sales of $40.000 million which missed the analyst consensus estimate of $52.050 million by 23.15 percent. This is a 34.28 percent decrease over sales of $60.864 million the same period last year.

Posted In: ME

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist